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Letter to the Editor
Electron Beam Computed Tomography
Dear Editor,
The ability of Electron Beam Computer
Tomography (EBT) to detect presence of coronary
calcification in asymptomatic patients has fueled much
debate regarding the appropriate use of this new imaging
modality.
It is apparent that the extent of calcification, in
terms of both an absolute volume and an age related
percentile score, is predictive of relative risk of coronary
artery events. It has also been demonstrated that risk
stratification by Coronary Calcium Scoring has
incremental value over "traditional risk assessment". As
Dr. Rumberger correctly points out: certain basic
epidemiological characteristics of EBT have been
defined (there is a low absolute risk of coronary artery
disease (CAD) with a zero coronary calcium score,
increased relative risk of events and increased likelihood
of angiographically significant CAD occurs with high
scores).
The source of the real debate is not these issues,
but rather whether and how this test should be
incorporated into routine clinical cardiology practice.
Firstly, should the test be used as a non-invasive test in
selected populations with intermediate risk of CAD or
as a screening test for the early detection of
atherosclerosis in unselected populations?
There are numerous factors regarding clinical
application of coronary calcium scoring that remain
undefined:

2.

3.
4.

1. How should the results of EBT influence the level
of aggressiveness of medical therapy in
asymptomatic patients? For instance:
5.
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a) Should a patient with a zero score continue with
standard primary prevention risk factor
modification? Are we doing these people an
injustice by providing false reassurance with a
"zero" score?
b) Does presence of any coronary calcium in an
asymptomatic patient indicate the need to move
to aggressive (secondary style) risk factor
modification? Should these patients be prescribed
aspirin?
c) What is the evidence that asymptomatic patients
with coronary calcium scores >75% for age
actually benefit from further investigations such
as stress testing? Although higher scores may be
associated with increased atherosclerotic burden,
what percentage of these patients actually have
inducible ischemia at stress testing? Preliminary
reports would suggest this percentage is low
unless the total calcium burden (Agatson score)
is greater than 400.1
What is the utility of serial coronary artery calcium
testing, particularly after initiation of medical
therapy? What do you say to a patient who has been
compliant with statin therapy but has multiple new
calcified lesions at follow up?
Is there a role for EBT in patients with prior
revascularization?
Where should EBT be placed in the testing algorithm
for symptomatic patients? Given that the risk of acute
events relates to unstable plaque, and risk
stratification in the presence of known coronary
artery disease has been shown to relate to the extent
of inducible ischemia and left ventricular function
is knowledge of the coronary calcium burden
additive or simply redundant information?
Numerous characteristics of plaque that has been
shown to relate to risk of plaque rupture cannot be
assessed by electronic beam computer tomography
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(i.e. plaque ulceration and surface contour, fibrous
cap, lipid content etc.). Given that a relatively small
amount of the total atherosclerotic plaque burden is
calcified plaque, the relationship between coronary
calcium scores and risk of acute events must be more
variable than Dr. Rumberger suggests. Testing for
plaque stability is the ideal approach and should be
incorporated into plaque imaging.
6. Most importantly, there is no information available
to date regarding the cost implications of coronary
artery calcium assessment in testing strategies for
symptomatic or asymptomatic patients in low or
intermediate risk groups. Calcium scoring has the
potential to generate considerable downstream costs
from non-invasive and invasive evaluations, or from
altered medical management strategies.
We agree with Dr. Rumberger that an extensive
literature exists validating that physiologically the
presence of coronary calcium has meaning. We also
agree that "coronary artery disease" can be defined today
either as the presence of a significant epicardial stenosis
(a traditional angiographic definition) or as the presence
of atherosclerosis as demonstrated by detection of
coronary artery plaque with or without associated
calcification. As pointed out by Dr. Rumberger,
electronic beam computer tomography is far superior
for identification of calcified plaque than for the
detection of patients with angiographically significant
stenosis.
Hence, as alluded to by Dr. Rumberger, despite
early claims that EBT would serve as a test to replace
conventional stress imaging, in light of its performance
characteristics this is unlikely to be the case. Rather,
EBT is one of a number of tests currently available to
clinicians for identification of the presence of preclinical
atherosclerosis (e.g. EBT, Intimal Medial Thickening,
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Ankle Brachial Index). In addition, there are an
increasing number of biochemical markers (such as high
sensitivity C-reactive Protein) gaining acceptance for
their ability to identify asymptomatic patients at risk of
adverse cardiac events.
The questions facing cardiologists today are
which combination of tests should be obtained in
clinical practice to identify those asymptomatic
patients at risk of events secondary to premature
atherosclerosis. And in the event of symptoms, which
combination of tests most accurately and efficiently
leads to diagnosis, risk stratification and formulation
of a management plan. EBT may well play an
important role as a component of an algorithm in the
future. However, this will only be the case after more
extensive data is collected validating it's performance
characteristics both individually and as part of a
testing algorithm.
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Yours sincerely,
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